184 related articles for article (PubMed ID: 32031519)
21. Proposed panel of diagnostic tools for accurate temporal classification of symptomatic T. gondii infection.
Barros GB; Lemos EM; E Silva-Dos-Santos PP; Dietze R; Zandonade E; Mineo JR; de Oliveira Silva DA; Pajuaba ACM; de Souza Gomes M; do Amaral LR; Coelho-Dos-Reis JG; Martins-Filho OA; Serufo JC
J Immunol Methods; 2017 Dec; 451():61-70. PubMed ID: 28882612
[TBL] [Abstract][Full Text] [Related]
22. Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.
Beghetto E; Spadoni A; Bruno L; Buffolano W; Gargano N
J Clin Microbiol; 2006 Jun; 44(6):2133-40. PubMed ID: 16757610
[TBL] [Abstract][Full Text] [Related]
23. [Problems and limitations of conventional and innovative methods for the diagnosis of Toxoplasmosis in humans and animals].
Piergili Fioretti D
Parassitologia; 2004 Jun; 46(1-2):177-81. PubMed ID: 15305712
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group.
Wilson M; Remington JS; Clavet C; Varney G; Press C; Ware D
J Clin Microbiol; 1997 Dec; 35(12):3112-5. PubMed ID: 9399504
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis.
Pietkiewicz H; Hiszczyńska-Sawicka E; Kur J; Petersen E; Nielsen HV; Paul M; Stankiewicz M; Myjak P
Parasitol Res; 2007 Jan; 100(2):333-7. PubMed ID: 16896649
[TBL] [Abstract][Full Text] [Related]
26. [Retrospective evaluation of serologic and molecular test results of toxoplasmosis suspected patients].
Erdoğan E; Yürük M; Sivcan E; Karaca S; Temel H; Şabanoğlu T; Gültekin A; Şahin İ
Mikrobiyol Bul; 2019 Jan; 53(1):96-105. PubMed ID: 30683043
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the efficiency of two commercial kits - ELFA and Western blot in estimating the phase of Toxoplasma gondii infection in pregnant women.
Sroka J; Wójcik-Fatla A; Zając V; Sawczyn A; Cisak E; Karamon J; Dutkiewicz J; Bojar I
Ann Agric Environ Med; 2016 Dec; 23(4):570-575. PubMed ID: 28030925
[TBL] [Abstract][Full Text] [Related]
28. Role of
Olariu TR; Blackburn BG; Press C; Talucod J; Remington JS; Montoya JG
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463899
[TBL] [Abstract][Full Text] [Related]
29. [Serological Investigation of Toxoplasma gondii on Pregnant Women and Toxoplasmosis Suspected Patients Between 2012-2014 Years on a Tertiary Training Hospital].
Selek MB; Bektöre B; Baylan O; Özyurt M
Turkiye Parazitol Derg; 2015 Sep; 39(3):200-4. PubMed ID: 26470925
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain.
Jacobs D; Vercammen M; Saman E
Clin Diagn Lab Immunol; 1999 Jan; 6(1):24-9. PubMed ID: 9874659
[TBL] [Abstract][Full Text] [Related]
31. Performance of a Western immunoblot assay to detect specific anti-Toxoplasma gondii IgG antibodies in human saliva.
Stroehle A; Schmid K; Heinzer I; Naguleswaran A; Hemphill A
J Parasitol; 2005 Jun; 91(3):561-3. PubMed ID: 16108547
[TBL] [Abstract][Full Text] [Related]
32. Comparison of serologic status of Toxoplasma gondii infection in pre- and post-heart transplantation in a pediatric population: A preliminary study.
Orang E; Sayyahfar S; Mahdavi M; Khanaliha K; Amiri M
Transpl Infect Dis; 2020 Aug; 22(4):e13339. PubMed ID: 32445414
[TBL] [Abstract][Full Text] [Related]
33. Significance of a Positive Toxoplasma Immunoglobulin M Test Result in the United States.
Dhakal R; Gajurel K; Pomares C; Talucod J; Press CJ; Montoya JG
J Clin Microbiol; 2015 Nov; 53(11):3601-5. PubMed ID: 26354818
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of LIPS (luciferase immunoprecipitation system) for serodiagnosis of Toxoplasmosis.
Aye KM; Nagayasu E; Baba M; Yoshida A; Takashima Y; Maruyama H
J Immunol Methods; 2018 Nov; 462():91-100. PubMed ID: 30201391
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the Vidas system and two recent fully automated assays for diagnosis and follow-up of toxoplasmosis in pregnant women and newborns.
Murat JB; Dard C; Fricker Hidalgo H; Dardé ML; Brenier-Pinchart MP; Pelloux H
Clin Vaccine Immunol; 2013 Aug; 20(8):1203-12. PubMed ID: 23740928
[TBL] [Abstract][Full Text] [Related]
36. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis.
Sensini A
Clin Microbiol Infect; 2006 Jun; 12(6):504-12. PubMed ID: 16700697
[TBL] [Abstract][Full Text] [Related]
37. Plasmonic gold chips for the diagnosis of Toxoplasma gondii, CMV, and rubella infections using saliva with serum detection precision.
Li X; Pomares C; Peyron F; Press CJ; Ramirez R; Geraldine G; Cannavo I; Chapey E; Levigne P; Wallon M; Montoya JG; Dai H
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):883-890. PubMed ID: 30701339
[TBL] [Abstract][Full Text] [Related]
38. Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women.
Jenum PA; Stray-Pedersen B
J Clin Microbiol; 1998 Oct; 36(10):2907-13. PubMed ID: 9738042
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii.
Roux-Buisson N; Fricker-Hidalgo H; Foussadier A; Rolland D; Suchel-Jambon AS; Brenier-Pinchart MP; Pelloux H
Diagn Microbiol Infect Dis; 2005 Sep; 53(1):79-81. PubMed ID: 16054325
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Toxoplasma gondii IgG avidity Architect and Vidas assays with the estimated date of infection in pregnant women.
Smets A; Fauchier T; Michel G; Marty P; Pomares C
Parasite; 2016; 23():45. PubMed ID: 27762213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
